|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and Cash Equivalent | ||||||||||||||||||||
| Marketable Securities, Current | ||||||||||||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease assets, net | ||||||||||||||||||||
| Software and website development costs, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Marketable securities, non-current | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, noncontrolling interests and shareholders’ deficit | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Temporary equity | ||||||||||||||||||||
| Redeemable noncontrolling interests (Note 14) | ||||||||||||||||||||
| Preferred shares, par value | ||||||||||||||||||||
| Preferred shares, shares authorized | ||||||||||||||||||||
| Common Stock, Value per Share | ||||||||||||||||||||
| Ordinary shares, shares authorized | ||||||||||||||||||||
| Shareholders’ deficit: | ||||||||||||||||||||
| Preferred shares, nominal value €0.01 per share, 100,000,000 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Ordinary shares, shares issued | ||||||||||||||||||||
| Common Stock, Shares, Outstanding | ||||||||||||||||||||
| Ordinary shares, nominal value €0.01 per share, 100,000,000 shares authorized; 42,318,634 and 42,448,572 shares issued, respectively; 24,347,387 and 24,477,325 shares outstanding, respectively | ||||||||||||||||||||
| Treasury Stock, Shares | ||||||||||||||||||||
| Treasury shares, at cost, 17,971,247 shares for both periods presented | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ deficit attributable to Cimpress plc | ||||||||||||||||||||
| Noncontrolling Interest | ||||||||||||||||||||
| Total shareholders' deficit | ||||||||||||||||||||
| Total liabilities, noncontrolling interests and shareholders’ deficit | ||||||||||||||||||||
Loading...
